nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Rivastigmine—Alzheimer's disease	0.157	0.432	CbGbCtD
Tiagabine—CYP3A4—Donepezil—Alzheimer's disease	0.125	0.345	CbGbCtD
Tiagabine—CYP3A4—Galantamine—Alzheimer's disease	0.0807	0.223	CbGbCtD
Tiagabine—SLC6A1—cerebellar cortex—Alzheimer's disease	0.0711	0.618	CbGeAlD
Tiagabine—SLC6A1—forebrain—Alzheimer's disease	0.0108	0.0938	CbGeAlD
Tiagabine—SLC6A1—telencephalon—Alzheimer's disease	0.00994	0.0863	CbGeAlD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—SLC18A3—Alzheimer's disease	0.00797	0.0833	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—PVRL2—Alzheimer's disease	0.00614	0.0642	CbGpPWpGaD
Tiagabine—SLC6A1—nervous system—Alzheimer's disease	0.00587	0.0509	CbGeAlD
Tiagabine—SLC6A1—central nervous system—Alzheimer's disease	0.00565	0.049	CbGeAlD
Tiagabine—SLC6A1—cerebellum—Alzheimer's disease	0.00552	0.0479	CbGeAlD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—CHAT—Alzheimer's disease	0.00477	0.0499	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—ACHE—Alzheimer's disease	0.0046	0.0481	CbGpPWpGaD
Tiagabine—SLC6A1—brain—Alzheimer's disease	0.00448	0.0389	CbGeAlD
Tiagabine—SLC6A1—Monoamine Transport—SLC6A4—Alzheimer's disease	0.00423	0.0442	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.00408	0.0426	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.00267	0.0279	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.00229	0.0239	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	0.00218	0.0228	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.00185	0.0194	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC18A3—Alzheimer's disease	0.00175	0.0183	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.00161	0.0168	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.00161	0.0168	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.00158	0.0165	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—Alzheimer's disease	0.00154	0.0161	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00152	0.0159	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.00137	0.0143	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.00137	0.0143	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00136	0.0142	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC6A4—Alzheimer's disease	0.00126	0.0131	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNA7—Alzheimer's disease	0.00123	0.0129	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIK1—Alzheimer's disease	0.00123	0.0129	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.00122	0.0128	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.00116	0.0121	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—Alzheimer's disease	0.00112	0.0117	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00107	0.0112	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.00106	0.0111	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.00105	0.011	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHAT—Alzheimer's disease	0.00105	0.011	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIK2—Alzheimer's disease	0.00105	0.011	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000989	0.0103	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000942	0.00984	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIA1—Alzheimer's disease	0.000935	0.00978	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—Alzheimer's disease	0.000934	0.00976	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000925	0.00967	CbGpPWpGaD
Tiagabine—CYP3A4—nervous system—Alzheimer's disease	0.000918	0.00797	CbGeAlD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000903	0.00944	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000894	0.00934	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNB2—Alzheimer's disease	0.000886	0.00926	CbGpPWpGaD
Tiagabine—CYP3A4—central nervous system—Alzheimer's disease	0.000884	0.00767	CbGeAlD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000882	0.00922	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000873	0.00912	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—AGER—Alzheimer's disease	0.000839	0.00877	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ACHE—Alzheimer's disease	0.000814	0.0085	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNA4—Alzheimer's disease	0.000804	0.00841	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000801	0.00837	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00077	0.00805	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BCHE—Alzheimer's disease	0.000709	0.00741	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—DLG4—Alzheimer's disease	0.000692	0.00723	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIN2B—Alzheimer's disease	0.000676	0.00707	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PLCB1—Alzheimer's disease	0.000669	0.00699	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000649	0.00679	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000645	0.00675	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000619	0.00648	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000615	0.00643	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000558	0.00584	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000515	0.00538	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000503	0.00526	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000495	0.00518	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PRKCG—Alzheimer's disease	0.000495	0.00517	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000482	0.00504	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000478	0.005	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000476	0.00497	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CALM1—Alzheimer's disease	0.000428	0.00447	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000428	0.00447	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000401	0.00419	CbGpPWpGaD
Tiagabine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000395	0.000926	CcSEcCtD
Tiagabine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000393	0.000922	CcSEcCtD
Tiagabine—Depression—Rivastigmine—Alzheimer's disease	0.000393	0.000921	CcSEcCtD
Tiagabine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000393	0.00092	CcSEcCtD
Tiagabine—Conjunctivitis—Memantine—Alzheimer's disease	0.000392	0.000918	CcSEcCtD
Tiagabine—Urinary tract infection—Memantine—Alzheimer's disease	0.000392	0.000918	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000391	0.00409	CbGpPWpGaD
Tiagabine—Cough—Galantamine—Alzheimer's disease	0.000391	0.000915	CcSEcCtD
Tiagabine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000389	0.000911	CcSEcCtD
Tiagabine—Renal failure—Rivastigmine—Alzheimer's disease	0.000388	0.000908	CcSEcCtD
Tiagabine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000386	0.000906	CcSEcCtD
Tiagabine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000386	0.000906	CcSEcCtD
Tiagabine—Hypertension—Galantamine—Alzheimer's disease	0.000386	0.000906	CcSEcCtD
Tiagabine—Haematuria—Memantine—Alzheimer's disease	0.000384	0.0009	CcSEcCtD
Tiagabine—Visual impairment—Donepezil—Alzheimer's disease	0.000384	0.0009	CcSEcCtD
Tiagabine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000383	0.000898	CcSEcCtD
Tiagabine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000383	0.000898	CcSEcCtD
Tiagabine—Arthralgia—Galantamine—Alzheimer's disease	0.000381	0.000893	CcSEcCtD
Tiagabine—Chest pain—Galantamine—Alzheimer's disease	0.000381	0.000893	CcSEcCtD
Tiagabine—Myalgia—Galantamine—Alzheimer's disease	0.000381	0.000893	CcSEcCtD
Tiagabine—Epistaxis—Memantine—Alzheimer's disease	0.00038	0.000891	CcSEcCtD
Tiagabine—Anxiety—Galantamine—Alzheimer's disease	0.00038	0.00089	CcSEcCtD
Tiagabine—Sinusitis—Memantine—Alzheimer's disease	0.000378	0.000886	CcSEcCtD
Tiagabine—Sweating—Rivastigmine—Alzheimer's disease	0.000378	0.000886	CcSEcCtD
Tiagabine—Discomfort—Galantamine—Alzheimer's disease	0.000377	0.000882	CcSEcCtD
Tiagabine—Haematuria—Rivastigmine—Alzheimer's disease	0.000376	0.000881	CcSEcCtD
Tiagabine—Dry mouth—Galantamine—Alzheimer's disease	0.000373	0.000873	CcSEcCtD
Tiagabine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000372	0.000871	CcSEcCtD
Tiagabine—Tinnitus—Donepezil—Alzheimer's disease	0.000372	0.000871	CcSEcCtD
Tiagabine—Sinusitis—Rivastigmine—Alzheimer's disease	0.00037	0.000867	CcSEcCtD
Tiagabine—Confusional state—Galantamine—Alzheimer's disease	0.000368	0.000863	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—CREB1—Alzheimer's disease	0.000366	0.00383	CbGpPWpGaD
Tiagabine—Haemoglobin—Memantine—Alzheimer's disease	0.000364	0.000852	CcSEcCtD
Tiagabine—Rhinitis—Memantine—Alzheimer's disease	0.000363	0.00085	CcSEcCtD
Tiagabine—Haemorrhage—Memantine—Alzheimer's disease	0.000362	0.000848	CcSEcCtD
Tiagabine—Hallucination—Memantine—Alzheimer's disease	0.00036	0.000844	CcSEcCtD
Tiagabine—Hypoaesthesia—Memantine—Alzheimer's disease	0.00036	0.000844	CcSEcCtD
Tiagabine—Shock—Galantamine—Alzheimer's disease	0.000359	0.000842	CcSEcCtD
Tiagabine—Pharyngitis—Memantine—Alzheimer's disease	0.000359	0.000841	CcSEcCtD
Tiagabine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000358	0.000838	CcSEcCtD
Tiagabine—Chills—Donepezil—Alzheimer's disease	0.000358	0.000838	CcSEcCtD
Tiagabine—Tachycardia—Galantamine—Alzheimer's disease	0.000357	0.000835	CcSEcCtD
Tiagabine—Oedema peripheral—Memantine—Alzheimer's disease	0.000356	0.000835	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000356	0.00372	CbGpPWpGaD
Tiagabine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000356	0.000834	CcSEcCtD
Tiagabine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000355	0.000832	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—TGFB1—Alzheimer's disease	0.000355	0.00371	CbGpPWpGaD
Tiagabine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000354	0.000829	CcSEcCtD
Tiagabine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000353	0.000828	CcSEcCtD
Tiagabine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000352	0.000825	CcSEcCtD
Tiagabine—Hallucination—Rivastigmine—Alzheimer's disease	0.000352	0.000825	CcSEcCtD
Tiagabine—Alopecia—Donepezil—Alzheimer's disease	0.000352	0.000825	CcSEcCtD
Tiagabine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000351	0.000823	CcSEcCtD
Tiagabine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000349	0.000817	CcSEcCtD
Tiagabine—Visual impairment—Memantine—Alzheimer's disease	0.000349	0.000817	CcSEcCtD
Tiagabine—Anorexia—Galantamine—Alzheimer's disease	0.000348	0.000816	CcSEcCtD
Tiagabine—Flatulence—Donepezil—Alzheimer's disease	0.000342	0.000801	CcSEcCtD
Tiagabine—Hypotension—Galantamine—Alzheimer's disease	0.000341	0.0008	CcSEcCtD
Tiagabine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000341	0.000799	CcSEcCtD
Tiagabine—Tension—Donepezil—Alzheimer's disease	0.00034	0.000798	CcSEcCtD
Tiagabine—Dysgeusia—Donepezil—Alzheimer's disease	0.00034	0.000796	CcSEcCtD
Tiagabine—Tinnitus—Memantine—Alzheimer's disease	0.000337	0.00079	CcSEcCtD
Tiagabine—Nervousness—Donepezil—Alzheimer's disease	0.000337	0.000789	CcSEcCtD
Tiagabine—Back pain—Donepezil—Alzheimer's disease	0.000336	0.000786	CcSEcCtD
Tiagabine—Muscle spasms—Donepezil—Alzheimer's disease	0.000334	0.000781	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000333	0.00078	CcSEcCtD
Tiagabine—Insomnia—Galantamine—Alzheimer's disease	0.00033	0.000774	CcSEcCtD
Tiagabine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00033	0.000773	CcSEcCtD
Tiagabine—Paraesthesia—Galantamine—Alzheimer's disease	0.000328	0.000769	CcSEcCtD
Tiagabine—Tremor—Donepezil—Alzheimer's disease	0.000325	0.000762	CcSEcCtD
Tiagabine—Somnolence—Galantamine—Alzheimer's disease	0.000325	0.000761	CcSEcCtD
Tiagabine—Chills—Memantine—Alzheimer's disease	0.000325	0.000761	CcSEcCtD
Tiagabine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000322	0.000754	CcSEcCtD
Tiagabine—Dyspepsia—Galantamine—Alzheimer's disease	0.000322	0.000754	CcSEcCtD
Tiagabine—Anaemia—Donepezil—Alzheimer's disease	0.000321	0.000751	CcSEcCtD
Tiagabine—Alopecia—Memantine—Alzheimer's disease	0.00032	0.000749	CcSEcCtD
Tiagabine—Agitation—Donepezil—Alzheimer's disease	0.000319	0.000747	CcSEcCtD
Tiagabine—Chills—Rivastigmine—Alzheimer's disease	0.000318	0.000744	CcSEcCtD
Tiagabine—Decreased appetite—Galantamine—Alzheimer's disease	0.000318	0.000744	CcSEcCtD
Tiagabine—Fatigue—Galantamine—Alzheimer's disease	0.000315	0.000738	CcSEcCtD
Tiagabine—Malaise—Donepezil—Alzheimer's disease	0.000313	0.000733	CcSEcCtD
Tiagabine—Alopecia—Rivastigmine—Alzheimer's disease	0.000313	0.000733	CcSEcCtD
Tiagabine—Constipation—Galantamine—Alzheimer's disease	0.000312	0.000732	CcSEcCtD
Tiagabine—Vertigo—Donepezil—Alzheimer's disease	0.000312	0.00073	CcSEcCtD
Tiagabine—Syncope—Donepezil—Alzheimer's disease	0.000311	0.000729	CcSEcCtD
Tiagabine—Flatulence—Memantine—Alzheimer's disease	0.00031	0.000727	CcSEcCtD
Tiagabine—Tension—Memantine—Alzheimer's disease	0.000309	0.000724	CcSEcCtD
Tiagabine—Dysgeusia—Memantine—Alzheimer's disease	0.000308	0.000723	CcSEcCtD
Tiagabine—Nervousness—Memantine—Alzheimer's disease	0.000306	0.000717	CcSEcCtD
Tiagabine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000305	0.000714	CcSEcCtD
Tiagabine—Back pain—Memantine—Alzheimer's disease	0.000305	0.000714	CcSEcCtD
Tiagabine—Flatulence—Rivastigmine—Alzheimer's disease	0.000304	0.000711	CcSEcCtD
Tiagabine—Cough—Donepezil—Alzheimer's disease	0.000303	0.000709	CcSEcCtD
Tiagabine—Tension—Rivastigmine—Alzheimer's disease	0.000302	0.000709	CcSEcCtD
Tiagabine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000302	0.000707	CcSEcCtD
Tiagabine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000301	0.000705	CcSEcCtD
Tiagabine—Hypertension—Donepezil—Alzheimer's disease	0.000299	0.000702	CcSEcCtD
Tiagabine—Nervousness—Rivastigmine—Alzheimer's disease	0.000299	0.000701	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000299	0.00313	CbGpPWpGaD
Tiagabine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000299	0.0007	CcSEcCtD
Tiagabine—Back pain—Rivastigmine—Alzheimer's disease	0.000298	0.000698	CcSEcCtD
Tiagabine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000296	0.000694	CcSEcCtD
Tiagabine—Chest pain—Donepezil—Alzheimer's disease	0.000295	0.000692	CcSEcCtD
Tiagabine—Arthralgia—Donepezil—Alzheimer's disease	0.000295	0.000692	CcSEcCtD
Tiagabine—Myalgia—Donepezil—Alzheimer's disease	0.000295	0.000692	CcSEcCtD
Tiagabine—Tremor—Memantine—Alzheimer's disease	0.000295	0.000691	CcSEcCtD
Tiagabine—Anxiety—Donepezil—Alzheimer's disease	0.000294	0.00069	CcSEcCtD
Tiagabine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000292	0.000685	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000292	0.00305	CbGpPWpGaD
Tiagabine—Discomfort—Donepezil—Alzheimer's disease	0.000292	0.000684	CcSEcCtD
Tiagabine—Anaemia—Memantine—Alzheimer's disease	0.000291	0.000682	CcSEcCtD
Tiagabine—Agitation—Memantine—Alzheimer's disease	0.000289	0.000678	CcSEcCtD
Tiagabine—Dry mouth—Donepezil—Alzheimer's disease	0.000289	0.000677	CcSEcCtD
Tiagabine—Abdominal pain—Galantamine—Alzheimer's disease	0.000289	0.000677	CcSEcCtD
Tiagabine—Body temperature increased—Galantamine—Alzheimer's disease	0.000289	0.000677	CcSEcCtD
Tiagabine—Tremor—Rivastigmine—Alzheimer's disease	0.000289	0.000676	CcSEcCtD
Tiagabine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000286	0.00067	CcSEcCtD
Tiagabine—Confusional state—Donepezil—Alzheimer's disease	0.000285	0.000669	CcSEcCtD
Tiagabine—Anaemia—Rivastigmine—Alzheimer's disease	0.000285	0.000667	CcSEcCtD
Tiagabine—Malaise—Memantine—Alzheimer's disease	0.000284	0.000666	CcSEcCtD
Tiagabine—Agitation—Rivastigmine—Alzheimer's disease	0.000283	0.000664	CcSEcCtD
Tiagabine—Oedema—Donepezil—Alzheimer's disease	0.000283	0.000663	CcSEcCtD
Tiagabine—Vertigo—Memantine—Alzheimer's disease	0.000283	0.000663	CcSEcCtD
Tiagabine—Syncope—Memantine—Alzheimer's disease	0.000282	0.000662	CcSEcCtD
Tiagabine—Leukopenia—Memantine—Alzheimer's disease	0.000282	0.000661	CcSEcCtD
Tiagabine—Infection—Donepezil—Alzheimer's disease	0.000281	0.000659	CcSEcCtD
Tiagabine—Shock—Donepezil—Alzheimer's disease	0.000279	0.000653	CcSEcCtD
Tiagabine—Palpitations—Memantine—Alzheimer's disease	0.000278	0.000652	CcSEcCtD
Tiagabine—Malaise—Rivastigmine—Alzheimer's disease	0.000278	0.000651	CcSEcCtD
Tiagabine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000277	0.00065	CcSEcCtD
Tiagabine—Vertigo—Rivastigmine—Alzheimer's disease	0.000277	0.000649	CcSEcCtD
Tiagabine—Loss of consciousness—Memantine—Alzheimer's disease	0.000277	0.000649	CcSEcCtD
Tiagabine—Syncope—Rivastigmine—Alzheimer's disease	0.000276	0.000647	CcSEcCtD
Tiagabine—Cough—Memantine—Alzheimer's disease	0.000275	0.000644	CcSEcCtD
Tiagabine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000274	0.000641	CcSEcCtD
Tiagabine—Palpitations—Rivastigmine—Alzheimer's disease	0.000272	0.000638	CcSEcCtD
Tiagabine—Hypertension—Memantine—Alzheimer's disease	0.000272	0.000637	CcSEcCtD
Tiagabine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000271	0.000635	CcSEcCtD
Tiagabine—Anorexia—Donepezil—Alzheimer's disease	0.00027	0.000632	CcSEcCtD
Tiagabine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000269	0.000631	CcSEcCtD
Tiagabine—Cough—Rivastigmine—Alzheimer's disease	0.000269	0.00063	CcSEcCtD
Tiagabine—Chest pain—Memantine—Alzheimer's disease	0.000268	0.000628	CcSEcCtD
Tiagabine—Myalgia—Memantine—Alzheimer's disease	0.000268	0.000628	CcSEcCtD
Tiagabine—Arthralgia—Memantine—Alzheimer's disease	0.000268	0.000628	CcSEcCtD
Tiagabine—Anxiety—Memantine—Alzheimer's disease	0.000267	0.000626	CcSEcCtD
Tiagabine—Hypertension—Rivastigmine—Alzheimer's disease	0.000266	0.000623	CcSEcCtD
Tiagabine—Discomfort—Memantine—Alzheimer's disease	0.000265	0.000621	CcSEcCtD
Tiagabine—Hypotension—Donepezil—Alzheimer's disease	0.000265	0.00062	CcSEcCtD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000264	0.00276	CbGpPWpGaD
Tiagabine—Chest pain—Rivastigmine—Alzheimer's disease	0.000262	0.000615	CcSEcCtD
Tiagabine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000262	0.000615	CcSEcCtD
Tiagabine—Myalgia—Rivastigmine—Alzheimer's disease	0.000262	0.000615	CcSEcCtD
Tiagabine—Dry mouth—Memantine—Alzheimer's disease	0.000262	0.000615	CcSEcCtD
Tiagabine—Asthenia—Galantamine—Alzheimer's disease	0.000262	0.000614	CcSEcCtD
Tiagabine—Anxiety—Rivastigmine—Alzheimer's disease	0.000261	0.000613	CcSEcCtD
Tiagabine—Confusional state—Memantine—Alzheimer's disease	0.000259	0.000607	CcSEcCtD
Tiagabine—Discomfort—Rivastigmine—Alzheimer's disease	0.000259	0.000607	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000258	0.000604	CcSEcCtD
Tiagabine—Oedema—Memantine—Alzheimer's disease	0.000257	0.000602	CcSEcCtD
Tiagabine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000257	0.000601	CcSEcCtD
Tiagabine—Insomnia—Donepezil—Alzheimer's disease	0.000256	0.0006	CcSEcCtD
Tiagabine—Infection—Memantine—Alzheimer's disease	0.000255	0.000598	CcSEcCtD
Tiagabine—Paraesthesia—Donepezil—Alzheimer's disease	0.000254	0.000596	CcSEcCtD
Tiagabine—Confusional state—Rivastigmine—Alzheimer's disease	0.000254	0.000594	CcSEcCtD
Tiagabine—Shock—Memantine—Alzheimer's disease	0.000253	0.000593	CcSEcCtD
Tiagabine—Dyspnoea—Donepezil—Alzheimer's disease	0.000252	0.000591	CcSEcCtD
Tiagabine—Somnolence—Donepezil—Alzheimer's disease	0.000252	0.00059	CcSEcCtD
Tiagabine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000252	0.00059	CcSEcCtD
Tiagabine—Oedema—Rivastigmine—Alzheimer's disease	0.000251	0.000589	CcSEcCtD
Tiagabine—Tachycardia—Memantine—Alzheimer's disease	0.000251	0.000588	CcSEcCtD
Tiagabine—Diarrhoea—Galantamine—Alzheimer's disease	0.00025	0.000586	CcSEcCtD
Tiagabine—Infection—Rivastigmine—Alzheimer's disease	0.00025	0.000585	CcSEcCtD
Tiagabine—Dyspepsia—Donepezil—Alzheimer's disease	0.000249	0.000584	CcSEcCtD
Tiagabine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000248	0.000582	CcSEcCtD
Tiagabine—Shock—Rivastigmine—Alzheimer's disease	0.000247	0.00058	CcSEcCtD
Tiagabine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000246	0.000577	CcSEcCtD
Tiagabine—Decreased appetite—Donepezil—Alzheimer's disease	0.000246	0.000577	CcSEcCtD
Tiagabine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000245	0.000575	CcSEcCtD
Tiagabine—Anorexia—Memantine—Alzheimer's disease	0.000245	0.000574	CcSEcCtD
Tiagabine—Fatigue—Donepezil—Alzheimer's disease	0.000244	0.000572	CcSEcCtD
Tiagabine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000243	0.00057	CcSEcCtD
Tiagabine—Pain—Donepezil—Alzheimer's disease	0.000242	0.000567	CcSEcCtD
Tiagabine—Constipation—Donepezil—Alzheimer's disease	0.000242	0.000567	CcSEcCtD
Tiagabine—Dizziness—Galantamine—Alzheimer's disease	0.000242	0.000566	CcSEcCtD
Tiagabine—Hypotension—Memantine—Alzheimer's disease	0.00024	0.000563	CcSEcCtD
Tiagabine—Anorexia—Rivastigmine—Alzheimer's disease	0.00024	0.000562	CcSEcCtD
Tiagabine—Hypotension—Rivastigmine—Alzheimer's disease	0.000235	0.000551	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000234	0.000549	CcSEcCtD
Tiagabine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000233	0.000547	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000233	0.00244	CbGpPWpGaD
Tiagabine—Insomnia—Memantine—Alzheimer's disease	0.000232	0.000545	CcSEcCtD
Tiagabine—Vomiting—Galantamine—Alzheimer's disease	0.000232	0.000544	CcSEcCtD
Tiagabine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000232	0.000542	CcSEcCtD
Tiagabine—Paraesthesia—Memantine—Alzheimer's disease	0.000231	0.000541	CcSEcCtD
Tiagabine—Rash—Galantamine—Alzheimer's disease	0.00023	0.00054	CcSEcCtD
Tiagabine—Dermatitis—Galantamine—Alzheimer's disease	0.00023	0.000539	CcSEcCtD
Tiagabine—Dyspnoea—Memantine—Alzheimer's disease	0.000229	0.000537	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000229	0.000537	CcSEcCtD
Tiagabine—Headache—Galantamine—Alzheimer's disease	0.000229	0.000536	CcSEcCtD
Tiagabine—Somnolence—Memantine—Alzheimer's disease	0.000229	0.000535	CcSEcCtD
Tiagabine—Insomnia—Rivastigmine—Alzheimer's disease	0.000227	0.000533	CcSEcCtD
Tiagabine—Dyspepsia—Memantine—Alzheimer's disease	0.000226	0.00053	CcSEcCtD
Tiagabine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000226	0.000529	CcSEcCtD
Tiagabine—Urticaria—Donepezil—Alzheimer's disease	0.000225	0.000527	CcSEcCtD
Tiagabine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000224	0.000525	CcSEcCtD
Tiagabine—Body temperature increased—Donepezil—Alzheimer's disease	0.000224	0.000524	CcSEcCtD
Tiagabine—Abdominal pain—Donepezil—Alzheimer's disease	0.000224	0.000524	CcSEcCtD
Tiagabine—Somnolence—Rivastigmine—Alzheimer's disease	0.000224	0.000524	CcSEcCtD
Tiagabine—Decreased appetite—Memantine—Alzheimer's disease	0.000223	0.000524	CcSEcCtD
Tiagabine—Fatigue—Memantine—Alzheimer's disease	0.000222	0.000519	CcSEcCtD
Tiagabine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000221	0.000519	CcSEcCtD
Tiagabine—Pain—Memantine—Alzheimer's disease	0.00022	0.000515	CcSEcCtD
Tiagabine—Constipation—Memantine—Alzheimer's disease	0.00022	0.000515	CcSEcCtD
Tiagabine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000219	0.000512	CcSEcCtD
Tiagabine—Nausea—Galantamine—Alzheimer's disease	0.000217	0.000508	CcSEcCtD
Tiagabine—Fatigue—Rivastigmine—Alzheimer's disease	0.000217	0.000508	CcSEcCtD
Tiagabine—Pain—Rivastigmine—Alzheimer's disease	0.000215	0.000504	CcSEcCtD
Tiagabine—Constipation—Rivastigmine—Alzheimer's disease	0.000215	0.000504	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000214	0.00223	CbGpPWpGaD
Tiagabine—Feeling abnormal—Memantine—Alzheimer's disease	0.000212	0.000496	CcSEcCtD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000211	0.00221	CbGpPWpGaD
Tiagabine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00021	0.000493	CcSEcCtD
Tiagabine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000209	0.000489	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000208	0.00217	CbGpPWpGaD
Tiagabine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000207	0.000486	CcSEcCtD
Tiagabine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000206	0.000482	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000205	0.00214	CbGpPWpGaD
Tiagabine—Urticaria—Memantine—Alzheimer's disease	0.000204	0.000479	CcSEcCtD
Tiagabine—Abdominal pain—Memantine—Alzheimer's disease	0.000203	0.000476	CcSEcCtD
Tiagabine—Body temperature increased—Memantine—Alzheimer's disease	0.000203	0.000476	CcSEcCtD
Tiagabine—Asthenia—Donepezil—Alzheimer's disease	0.000203	0.000476	CcSEcCtD
Tiagabine—Pruritus—Donepezil—Alzheimer's disease	0.0002	0.000469	CcSEcCtD
Tiagabine—Urticaria—Rivastigmine—Alzheimer's disease	0.0002	0.000468	CcSEcCtD
Tiagabine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000199	0.000466	CcSEcCtD
Tiagabine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000199	0.000466	CcSEcCtD
Tiagabine—Diarrhoea—Donepezil—Alzheimer's disease	0.000194	0.000454	CcSEcCtD
Tiagabine—Hypersensitivity—Memantine—Alzheimer's disease	0.000189	0.000444	CcSEcCtD
Tiagabine—Dizziness—Donepezil—Alzheimer's disease	0.000187	0.000439	CcSEcCtD
Tiagabine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000185	0.000434	CcSEcCtD
Tiagabine—Asthenia—Memantine—Alzheimer's disease	0.000184	0.000432	CcSEcCtD
Tiagabine—Pruritus—Memantine—Alzheimer's disease	0.000182	0.000426	CcSEcCtD
Tiagabine—Asthenia—Rivastigmine—Alzheimer's disease	0.00018	0.000423	CcSEcCtD
Tiagabine—Vomiting—Donepezil—Alzheimer's disease	0.00018	0.000422	CcSEcCtD
Tiagabine—Rash—Donepezil—Alzheimer's disease	0.000179	0.000418	CcSEcCtD
Tiagabine—Dermatitis—Donepezil—Alzheimer's disease	0.000178	0.000418	CcSEcCtD
Tiagabine—Pruritus—Rivastigmine—Alzheimer's disease	0.000178	0.000417	CcSEcCtD
Tiagabine—Headache—Donepezil—Alzheimer's disease	0.000177	0.000416	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000177	0.00185	CbGpPWpGaD
Tiagabine—Diarrhoea—Memantine—Alzheimer's disease	0.000176	0.000412	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000173	0.00181	CbGpPWpGaD
Tiagabine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000172	0.000403	CcSEcCtD
Tiagabine—Dizziness—Memantine—Alzheimer's disease	0.00017	0.000398	CcSEcCtD
Tiagabine—Nausea—Donepezil—Alzheimer's disease	0.000168	0.000394	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000167	0.00175	CbGpPWpGaD
Tiagabine—Dizziness—Rivastigmine—Alzheimer's disease	0.000166	0.00039	CcSEcCtD
Tiagabine—Vomiting—Memantine—Alzheimer's disease	0.000163	0.000383	CcSEcCtD
Tiagabine—Rash—Memantine—Alzheimer's disease	0.000162	0.00038	CcSEcCtD
Tiagabine—Dermatitis—Memantine—Alzheimer's disease	0.000162	0.000379	CcSEcCtD
Tiagabine—Headache—Memantine—Alzheimer's disease	0.000161	0.000377	CcSEcCtD
Tiagabine—Vomiting—Rivastigmine—Alzheimer's disease	0.00016	0.000375	CcSEcCtD
Tiagabine—Rash—Rivastigmine—Alzheimer's disease	0.000159	0.000372	CcSEcCtD
Tiagabine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000158	0.000371	CcSEcCtD
Tiagabine—Headache—Rivastigmine—Alzheimer's disease	0.000158	0.000369	CcSEcCtD
Tiagabine—Nausea—Memantine—Alzheimer's disease	0.000153	0.000358	CcSEcCtD
Tiagabine—Nausea—Rivastigmine—Alzheimer's disease	0.000149	0.00035	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000124	0.00129	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	9.39e-05	0.000981	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	9.21e-05	0.000962	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.08e-05	0.000949	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.32e-05	0.000556	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.52e-05	0.000473	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.25e-05	0.000445	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.03e-05	0.000422	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.85e-05	0.000402	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.69e-05	0.000386	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.55e-05	0.000371	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.43e-05	0.000358	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.21e-05	0.000231	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.21e-05	0.000231	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.12e-05	0.000221	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.04e-05	0.000213	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.97e-05	0.000206	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.71e-05	0.000179	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.69e-05	0.000177	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.61e-05	0.000168	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.61e-05	0.000168	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.57e-05	0.000165	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.49e-05	0.000156	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.41e-05	0.000147	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.36e-05	0.000143	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.18e-05	0.000123	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.17e-05	0.000122	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.07e-05	0.000112	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.64e-06	0.000101	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.01e-06	9.42e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.98e-06	9.39e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	8.9e-06	9.3e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	7.82e-06	8.17e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—INS—Alzheimer's disease	7.67e-06	8.02e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.73e-06	7.03e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.15e-06	6.43e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.09e-06	3.23e-05	CbGpPWpGaD
